News

Chief Product Officer for Proscia, Nathan Buchbinder, discusses Proscia’s Concentriq and its benefits for CROs and life science organziations.

The recent industry-wide focus on widened access to health care, patient-centric approaches, and high-quality care have increased the interest in the concept of clinical research as a care option, Customer Project Manager of Trialbee, Hannah Van de Meek writes.

Integrating a systemic risk management strategy for identifying clinical trial risks-and the importance of applying change management techniques throughout the preparation, planning, and execution stages.

Outlining the latest government, industry, and public health efforts to promote increased adoption of common standards in data collection and sharing.

FDA released four new draft guidances that seek to broaden criteria for identifying and enrolling patients in clinical trials in an effort to reduce time and cost of clinical research for biopharmaceuticals.

A statement from Europe’s drug industry and Europe’s medical societies calls for a “bold vision” to ensure proper funding and coordination for translational research.

CROs should be more mindful of their smaller emerging biopharma clients and pay more attention to handling their needs.

The “citizen data scientist” is the person with no official data scientist training who uses the latest tools and technologies to handle data wrangling duties, analyze data, and create reports and models.

A leading industry executive in the regenerative medicine space discusses recent advances in stem cell therapy development.

Click the title above to open the Applied Clinical Trials April 2019 issue in an interactive PDF format.

Executives from DIA, Ranjini Prithviraj and Sudip Parikh discuss documents the FDA released that further detail the agency’s implementation plan for its Software Precertification Pilot Program.